The effect of anesthesia and surgery on CYP3A activity in rats

Drug Metabolism and Disposition

Volumn 32, Issue 11, 2004, Pages 1325-1330

  Uhing, Michael R ^a   Beno, David W A ^a   Jiyamapa Serna, Vanida A ^a   Chen, Yong ^a   Galinsky, Raymond E ^b,c,d   Hall, Stephen D ^c   Kimura, Robert E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CYTOCHROME P450 3A; KETAMINE; MACROGOL 4000; MIDAZOLAM; XYLAZINE;

ANESTHESIA; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD VESSEL CATHETERIZATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; ENZYME ACTIVITY; INDWELLING CATHETER; LIVER BLOOD FLOW; MALE; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; SUPERIOR MESENTERIC ARTERY; SURGERY;

ANESTHETICS; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CATHETERIZATION; CYTOCHROME P-450 CYP3A; ENZYME ACTIVATION; ENZYME INHIBITORS; MALE; OXIDOREDUCTASES, N-DEMETHYLATING; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 6944224050     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.000927     Document Type: Article

References (23)

1. Beno DW, Uhing MR, Goto M, Chen Y, Jiyamapa-Serna VA, and Kimura RE (2001) Endotoxin-induced reduction in biliary indocyanine green excretion rate in a chronically catheterized rat model. Am J Physiol 280:G858-G865.
2. Cleton A, Voskuyl RA, and Danhof M (1998) Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy. Br J Pharmacol 125:615-620.
3. Cohn SM, Cohn KA, Rafferty MJ, Smith AH, Degutis LC, Kowalsky SF, and Shah A (1995) Enteric absorption of ciprofloxacin during the immediate postoperative period. J Antimicrob Chemother 36:717-721.
4. Colombato LA, Sabba C, Polio J, and Groszmann RJ (1991) Influence of anesthesia, postanesthetic state and restraint on superior mesenteric arterial flow in normal rats. Am J Physiol 260:G1-G6.
5. Corbic M, Lebrec D, Le Dafniet M, and Erlinger S (1984) A new method to measure portal and hepatic blood flow using taurocholate in the rat. Hepatology 4:112-115.
6. Cummins CL, Salphati L, Reid MJ, and Benet LZ (2003) In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model. J Pharmacol Exp Ther 305:306-314.
7. Elfant AB, Levine SM, Cencora B, Spiegel TA, Mendez L, Pello MJ, Alexander JB, Atabek U, Camishion RC, and Peikin SR (1995) Bioavailability of medication after laparoscopic cholecystectomy. J Laparoendosc Surg 5:237-240.
8. Gumbleton M, Nicholls PJ, and Taylor G (1990a) Differential influence of laboratory anaesthetic regimens upon renal and hepatosplanchnic haemodynamics in the rat. J Pharm Pharmacol 42:693-697.
9. Gumbleton M, Nicholls PJ, and Taylor G (1990b) Differential effects of anesthetic regimens on gentamicin pharmacokinetics in the rat: a comparison with chronically catheterized conscious animals. Pharm Res (NY) 7:41-45.
10. Guyton AC, Jones CE, and Coleman TG (1973) Circulatory Physiology: Cardiac Output and its Regulation. W.B. Saunders, Philadelphia.
11. Matsubara T, Kim H, Miyata M, Shimada M, Nagata K, and Yamazoe Y (2004) Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat. J Pharmacol Exp Ther 309:1282-1290.
12. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162.
13. Pang KS and Rowland M (1977) Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 5:625-653.
14. Richter S, Vollmar B, Mucke I, Post S, and Menger MD (2001) Hepatic arteriolo-portal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers. J Physiol 531:193-201.
15. Schuitmaker M, Anderson BJ, Holford NH, and Woollard GA (1999) Pharmacokinetics of paracetamol in adults after cardiac surgery. Anaesthesiol Intensive Care 27:615-622.
16. Shaw AA, Hall SD, Franklin MR, and Galinsky RE (2002) The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition. Drug Metab Dispos 30:177-182.
17. Singh G, Chaudry KI, Chudler LC, O'Neill PJ, and Chaudry IH (1991) Measurement of D-xylose gut absorptive capacity in conscious rats. Am J Physiol 261:R1313-R1320.
18. Thummel K and Wilkinson G (1998) In vitro and in vivo drug interactions involving human CYP3A. Ann Rev Pharmacol Toxicol 38:389-430.
19. Ueda S, Yamaoka K, and Nakagawa T (1999) Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference. J Pharm Pharmacol 51:585-589.
20. Uhing MR and Arango V (1997) Intestinal absorption of proline and leucine in chronically catheterized rats. Gastroenterology 113:865-874.
21. Uhing MR and Kimura RE (1995) The effect of surgical bowel manipulation and anesthesia on intestinal glucose absorption in rats. J Clin Investig 95:2790-2798.
22. Visser SA, Huntjens DR, van der Graaf PH, Peletier LA, and Danhof M (2003) Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats. J Pharmacol Exp Ther 307:765-775.
23. Winne D, Kopf S, and Ulmer ML (1979) Role of unstirred layer in intestinal absorption of phenylalanine in vivo. Biochim Biophys Acta 550:120-130.